4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Anti-Bacterial Agents: new trials by email Literature Review of Anti-Bacterial Agents trials Research Report on Anti-Bacterial Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neuroimmune Dysfunction in Alcohol Use Disorder Minocycline, Sugar pill - Alcohol Drinking, Alcohol-Related Disorders | Phase 1 | Completed | University of Maryland, Baltimore | 142 | 2020-02-03 | 2023-12-01 |
| A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers N-Rephasin® SAL200, INT200-Placebo - Healthy Volunteers, Anti-Bacterial Agents | Phase 1 | Completed | Intron Biotechnology, Inc. | 33 | 2018-02-07 | 2021-11-03 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers N-Rephasin® SAL200, INT200-Placebo - Healthy Volunteers, Anti-Bacterial Agents | Phase 1 | Completed | Intron Biotechnology, Inc. | 36 | 2013-08-06 | 2021-11-03 |
| An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice Educational intervention, Educational intervention program - Respiratory Tract Infections, Anti-Bacterial Agents | Phase 1 / Phase 2 | Completed | University of Oslo | 118621 | 2006-01-01 | 2010-04-27 |
Alcohol Drinking (1) · Alcohol-Related Disorders (1) · Alcoholism (1) · Chemically-Induced Disorders (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Disease (1) · Drinking Behavior (1) · Inflammation (1) · Mental Disorders (1) · Neurocognitive Disorders (1) · Pathologic Processes (1) · Respiratory Tract Infections (1) · Substance-Related Disorders (1) · cyclopia sequence (1)
Behavior (1) · Infections (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1)
Early Intervention, Educational (1) · Minocycline (1) · Sugars (1)
Intron Biotechnology, Inc. (2) · University of Maryland, Baltimore (1) · University of Oslo (1)
South Korea (2) · Norway (1) · United States (1)
In Jin Jang, M.D., Ph. D. (2) · Svein Gjelstad, MD (1)
PMID 11739958, PMID 12808158, PMID 14576095, PMID 15979390, PMID 16776824, PMID 18824123, PMID 23299114, PMID 23894178, PMID 28348152, PMID 35007129, PMID 40483726
K01AA026005 (1)